These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6148792)

  • 41. [Neurologic and psychic complications in treatment with neuroleptics].
    Gerlach J
    Ugeskr Laeger; 1976 Jun; 138(27):1650-3. PubMed ID: 951778
    [No Abstract]   [Full Text] [Related]  

  • 42. The abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients.
    Carter G
    Br J Psychiatry; 1983 Feb; 142():166-8. PubMed ID: 6132644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The concept of supersensitivity psychosis. The particular case of clozapine].
    Llorca PM; Penault F; Lançon C; Dufumier E; Vaiva G
    Encephale; 1999; 25(6):638-44. PubMed ID: 10668609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
    Luchins DJ; Freed WJ; Wyatt RJ
    Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Parkinsonism during lithium use].
    Walrave TR; Bulens C
    Tijdschr Psychiatr; 2009; 51(2):123-7. PubMed ID: 19194854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.
    Jeste DV; Gilbert PL; McAdams LA; Harris MJ
    Arch Gen Psychiatry; 1995 Mar; 52(3):209-12. PubMed ID: 7872848
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pharmacotoxic psychoses in patients with neurological disorders during old age (author's transl)].
    Danielczyk W
    Aktuelle Gerontol; 1979 Sep; 9(9):427-31. PubMed ID: 44122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Motor and mental side effects of clozapine.
    Gerlach J; Peacock L
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olanzapine: a proarrhythmic drug?
    Gupta N; Malhotra P
    Can J Psychiatry; 2002 Sep; 47(7):683-4. PubMed ID: 12355682
    [No Abstract]   [Full Text] [Related]  

  • 50. Anticholinergic equivalents and parkinsonism: a model for predicting side-effects of antipsychotic drugs.
    Menkes DB; Clarkson HO; Caradoc-Davies G; Mullen PE
    Int Clin Psychopharmacol; 1987 Jan; 2(1):55-67. PubMed ID: 2889760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Long-term complications of treatment with levodopa].
    Castro García A; Sesar Ignacio A
    Neurologia; 1998; 13 Suppl 1():41-8. PubMed ID: 9859685
    [No Abstract]   [Full Text] [Related]  

  • 52. Parkinsonism and tardive dyskinesia.
    Crane GE
    Am J Psychiatry; 1978 May; 135(5):619-20. PubMed ID: 645966
    [No Abstract]   [Full Text] [Related]  

  • 53. [The risk of neuroleptic discontinuation in schizophrenia].
    Jarema M
    Psychiatr Pol; 1999; 33(1):69-81. PubMed ID: 10786216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New perspectives in the treatment of the motor complications associated with chronic treatment of Parkinson disease].
    Linazasoro G
    Neurologia; 1999 Oct; 14(8):393-406. PubMed ID: 10609463
    [No Abstract]   [Full Text] [Related]  

  • 55. Antipsychotic-induced movement disorders - forgotten but not gone.
    Weiden PJ
    Acta Psychiatr Scand; 2008 Jun; 117(6):401-2. PubMed ID: 18479315
    [No Abstract]   [Full Text] [Related]  

  • 56. Parkinsonism following neuroleptic withdrawal.
    Nelli AC; Yarden PE; Guazzelli M; Feinberg I
    Arch Gen Psychiatry; 1989 Apr; 46(4):383-4. PubMed ID: 2564765
    [No Abstract]   [Full Text] [Related]  

  • 57. [Drug-induced neurologic disorders. I. Central nervous system (author's transl)].
    Manigand G
    Therapie; 1982; 37(2):113-41. PubMed ID: 6126015
    [No Abstract]   [Full Text] [Related]  

  • 58. Tardive blepharospasm beginning after withdrawal of veralipride.
    Alonso-Navarro H; Jiménez-Jiménez FJ
    Mov Disord; 2006 Nov; 21(11):2033-4. PubMed ID: 16960858
    [No Abstract]   [Full Text] [Related]  

  • 59. Portable device for quantifying parkinsonian wrist rigidity.
    Caligiuri MP
    Mov Disord; 1994 Jan; 9(1):57-63. PubMed ID: 7908119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anticholinergic agents. Drug addiction and dangerous withdrawal].
    Betermiez P; Pedinielli JL; Blondiaux B; Delahousse J; Mizon JP
    Therapie; 1987; 42(6):559-60. PubMed ID: 3441899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.